A Retreatment Study With Bortezomib for Multiple Myeloma

Clinical trial NCT01030302 · COMPLETED

Trial details

NCT number: NCT01030302
Sponsor: Janssen Korea, Ltd., Korea
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2008-11-01
Primary completion: 2010-09-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.